The heterogeneous pathology of tauopathies and the differential susceptibility of different neuronal types to WT (wild-type) and mutant tau suggest that phosphorylation at particular sites rather than hyperphosphorylation mediates toxicity or dysfunction in a cell-type-specific manner. Pan-neuronal accumulation of tau in the Drosophila CNS (central nervous system) specifically affected the MBs (mushroom body neurons), consistent with neuronal type-specific effects. The MB aberrations depended, at least in part, on occupation of two novel phosphorylation sites: Ser 238 and Thr 245 . The degree of isoform-specific MB aberrations was paralleled by defects in associative learning, as blocking putative Ser 238 and Thr 245 phosphorylation yielded structurally normal, but profoundly dysfunctional, MBs, as animals accumulating the mutant protein exhibited strongly impaired associative learning. Similarly dysfunctional MBs were obtained by temporally restricting tau accumulation to the adult CNS, which also altered the tau phosphorylation pattern. Our data clearly distinguish tau-dependent neuronal degeneration and dysfunction and suggest that temporal differences in occupation of the same phosphorylation sites are likely to mediate these distinct effects of tau.
Introduction
Tau is a predominantly axonal microtubule-associated phosphoprotein [1, 2] . In Alzheimer's disease and a variety of sporadic neurodegenerative disorders with distinct and heterogeneous pathologies collectively referred to as tauopathies, it aggregates as neuronal cytoplasmic inclusions known as NFTs (neurofibrillary tangles) [3, 4] . One of the correlative distinguishing features of various tauopathies is the composition of the cytoplasmic inclusions, which may contain predominantly proteins of three microtubule-binding repeats (3R) or four microtubule-binding repeats (4R) or a mixture of both [5] . The functional significance of the various tau isoforms is currently unknown. Understanding the precise role of tau in the disease process becomes even more complicated when another important characteristic of tauopathies is taken into account: the differential vulnerability of distinct nerve cell types to tau [6] . These specific patterns of neurodegeneration suggest differential sensitivity of neuronal populations to the overall level of the protein, its phosphorylation status and mutations. Models of tau overaccumulation have been developed in both vertebrate [7, 8] and invertebrate systems [9] [10] [11] . The consequent phenotypes that generally emulate clinical features of the human diseases are neuronal loss and learning and memory defects, the latter often without apparent NFTs [12] [13] [14] . In fact, repressing transgenic tau in a mouse model attenuated the memory impairment and neuronal loss, but NFTs continued to accumulate [15] .
We utilized transgenic fruitflies carrying human tau genes expressed under the UAS (upstream activator sequence)/Gal4 system [16, 17] , the prime tool of the Drosophila molecular arsenal, to investigate the molecular hallmarks associated with tau-dependent neuronal dysfunction manifested as impairments in learning and memory. We hypothesize that these cognitive impairments have an aetiology distinct from those associated with neurodegeneration and, as such, the two should be separable genetically. To that end, we have shown that human tau accumulation, specifically in the adult Drosophila MBs (mushroom body neurons), the functional analogue of the vertebrate hippocampus [18] , impairs associative learning and memory, thus causing dysfunction without apparent neurodegeneration [19, 20] . In the present paper, we report on work that has extended these initial studies by expressing WT (wild-type) tau isoforms throughout the Drosophila CNS (central nervous system), instead of just in the MBs. We have investigated whether specific neuronal populations are affected differentially, either structurally or functionally, and whether such putative effects depend on the different WT tau isoforms. Finally, we would like to determine whether phosphorylation at specific sites is implicated in tau-induced anatomical or functional defects.
Figure 1 Structural and functional effects of tau isoforms
(A) Differential effects on MB integrity of different WT human tau isoforms upon accumulation under the pan-neuronal driver Elav-Gal4. Images are Carnoy's-fixed paraffin-embedded frontal sections, at the level of calyces and α/β lobes, stained with anti-Leonardo, as described previously [20, 22] . (B) Summary of MB structural defects precipitated by accumulation of the 0N4R isoform under the indicated Gal4 drivers. The Drosophila life stages during which driver expression is turned on are marked with +. The smaller crosses indicate low Gal4 expression at the particular developmental stage. NBs, neuroblasts;
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E-, L, P, A-CNS, embryonic, larval, pupal and adult CNS respectively; A-MBs, adult MBs. (C) Associative olfactory learning performance of animals accumulating tau variants pan-neuronally with or without MB structural aberrations. Carnoy's-fixed paraffin-embedded frontal sections at the level of α/β lobes are shown for clarity in the top row. Behavioural analysis was performed as described previously [27] . Driver heterozygotes alone were used as controls (black bar). Results are means ± S.E.M. (D) Microtubule-binding assays for five different tau variants. Head extracts of fruitflies expressing tau pan-neuronally were treated with the microtubule-stabilizing drug taxol and were spun at 13 000 g for 1 h at 4 • C. Fruitflies not expressing a transgene were used as control (+). The supernatant (S) and pellet (P) fractions were collected and analysed by immunoblotting with monoclonal TAU5 antibody (Tau) (CalBiochem). Tubulin was detected with an anti-tubulin monoclonal antibody (Tub) (E7, Developmental Studies Hybridoma Bank).
to WT tau. Furthermore, we investigated whether the Nterminal extensions (N) and number of microtubule-binding repeats (R) influence such putative phenotype. Thus we expressed 0N3R, 0N4R and 2N4R human isoforms throughout the Drosophila CNS with the pan-neuronal driver Elav [20] , as reported previously [21] . Surprisingly, accumulation of 0N3R did not precipitate any obvious defects, in contrast with 0N4R and 2N4R isoforms that resulted in severe and specific MB defects, with the longest tau isoform yielding slightly more severe structural defects [22] ( Figure 1A ). The differences in consequences of the isoforms are not the result of differences in protein accumulation as shown previously [22] . Therefore the MBs are differentially sensitive to ubiquitous 4R tau accumulation in the CNS, and the size of the N-terminal extensions has little effect on toxicity.
Of equal interest is the finding that these MB defects arise during the first 6 h of embryogenesis and result from the loss of MBNBs (MB neuroblasts) [22] . This is also demonstrated by using Gal4 drivers with restricted spatiotemporal onset of expression, shown in Figure 1 (B). In agreement with the embryonic origin of the phenotype, 0N4R tau expression under the pan-neuronal APPL (amyloid precursor protein-like)-Gal4 driver, turned on during late embryogenesis (stage 15) [23] , did not yield any detectable MB defects, in contrast with the early embryonic accumulation of tau in neuroblasts including those of the MBs under Elav [24] . Consistently, accumulation of tau in embryonic MB neuroblasts under OK107-Gal4 [25] resulted in obvious MB aberrations, but with a milder phenotype compared with Elav. A lower level of or delayed protein expression under OK107 in MBNBs may account for this difference. As expected, drivers 201Y and 238Y, that direct expression mostly during larval stages, had no effect on MB morphology. Similarly, the MBs appeared unaffected under c492 and c772, two Gal4 drivers expressed in late pupae and mostly adult MB neurons [26] , in agreement with previous results [20] . Therefore tau toxicity is exerted on MB neuroblasts, a situation potentially akin to the recently proposed effects of tau on neural stem cells in the dentate gyrus and subventicular zone of adult vertebrate brains [27] .
To assess the learning abilities of fruitflies expressing tau isoforms pan-neuronally, we used the well-established Pavlovian olfactory conditioning paradigm [20, 28, 29] . Learning in this paradigm is MB-mediated and can be assessed by training the fruitflies to associate an electric shock with a particular unpleasant odour. The decrement of this associative learning is a very sensitive measure of the functional integrity of MBs [30] . Not surprisingly, olfactory learning was nearly abolished in adult animals accumulating 0N4R and 2N4R isoforms because of their structurally aberrant MBs ( Figure 1C , upper panels). This indicates that the previously reported learning deficits upon WT tau accumulation on the fruitfly CNS [19] are consequences of the aberrant MBs. In contrast, the 0N3R isoform did not affect the MBs structurally, and learning was not significantly different from controls ( Figure 1C , black bar). The results with the 0N3R human tau and the 2N4R BTau (bovine tau) are significant, because they clearly demonstrate that the structural effects of tau on MBs, or on the functional processes that underlie learning, do not result from generalized nonspecific toxicity of these vertebrate proteins. Rather, these deficits are neuron-type-and tau-isoform-specific.
Novel phosphorylation sites on human WT tau required for MB toxicity
Significantly, accumulation of BTau strongly impaired learning without obvious effects on the structural integrity of MBs. The phenotypic manifestation differences between the highly homologous human 2N4R and the bovine 2N4R tau led us to investigate their cause. Sequence comparison of these two proteins revealed that, although their N-termini are somewhat divergent, they differ only by three amino acids in the otherwise identical microtubule-binding domain [22] . Two of these amino acids are the phosphorylatable Ser 238 and Thr 245 within the critical region typically associated with tau pathogenicity (see Figure 3A) . To determine whether these sites contribute to tau toxicity in the MBs, Ser 238 and Thr 245 of the longest and most commonly associated with tauopathies 2N4R isoform, were mutated to alanine residues (2N4R-STA). Blocking these two novel putative phosphorylation sites eliminated toxicity in MBs, but, although intact, neurons accumulating 2N4R-STA could not support associative learning ( Figure 1C ). These results are important for three reasons. First, these data indicate that phosphorylation on one or both of these novel sites is required for toxicity, and, secondly, they demonstrate that MB toxicity is clearly dissociable from dysfunction. Thirdly, these two sites have been detected to be phosphorylated in brains from Alzheimer's patients [5] . Thus our data provide strong functional evidence that these phosphorylations are likely to be involved in the disease. Finally, these data provide direct support for our overall hypothesis that tau toxicity and tau-mediated dysfunction are separable and identify Ser 238 , Thr 245 or both as critical for this distinction. Ongoing work is aimed at determining whether these sites are actually phosphorylated and whether both are required for tau toxicity in Drosophila.
In order to assess the microtubule-binding properties of the different taus, as a potential factor that could affect tau-induced toxicity or dysfunction, we carried out microtubule-binding assays by incubating adult head extracts with the microtubule-stabilizing drug taxol. After centrifugation of the extracts, almost all of the 0N4R, 2N4R and BTau isoforms were detected in the microtubulebound pellet (P) fraction ( Figure 1D ). In the case of 0N3R and 2N4R-STA proteins, we detected distribution of the proteins in both the supernatant and pellet fractions, most prominently for 0N3R. Therefore differences in microtubule-binding affinity cannot explain the differential effects of tau isoforms on MB toxicity and dysfunction.
Limiting pan-neuronal tau accumulation to adult animals eliminates its structural, but not the functional, effects on the MBs
Our results demonstrating separation of tau toxicity and dysfunction predict that if the protein is not present in neuroblasts, then 0N4R and 2N4R expressed specifically in adults should precipitate learning deficits in animals with structurally intact MBs. To address this prediction, we controlled expression of the 0N4R and 2N4R isoforms spatiotemporally using the TARGET (Temporal And Regional Gene Expression Targeting) system [17, 31] . Crosses were performed at 18
• C where Gal4 activity is repressed by the temperature-sensitive Gal80 ts , and expression of the transgene was induced in adult fruitflies by shifting them to 30
• C for various lengths of time. Interestingly, acute expression of tau transgenes with this system may emulate sporadic tauopathies. The accumulation profile of 0N4R from 24 to 168 h (7 days) is shown in Figure 2(A) . It is notable that the protein appears to attain steady state after 48 h of induction as little increase in its levels is observed in samples collected later. As expected, restricted expression of tau in adult neurons did not result in structurally altered MBs ( Figure 2B ), even after continued tau accumulation at 30
• C for up to 7 days. However, even though these animals retain normal MB morphology, their performance in the olfactory associative learning task was significantly impaired, especially as tau levels appeared to attain steady state ( Figure 2C ). Similar results were obtained with the 2N4R protein (not shown, but see Figure 3D ). Thus, in agreement with the notion that toxicity and dysfunction are separable, even the most toxic tau isoform for MB development only impairs MB-mediated learning if expressed specifically in the adult CNS. and Ser 356 over that on WT 2N4R is a characteristic of 2N4R-STA. Consistent with the proposed role of Par1 phosphorylation of these sites as initiators for Thr 212 and Ser 214 (AT100) occupation, the AT100 epitope was highly phosphorylated in 2N4R-STA as well [22] . AT100 is a site typically used in the diagnosis of NFTs in Alzheimer's disease [33, 34] and thus has been linked primarily with neurodegeneration. However, since accumulation of 2N4R-STA does not lead to detectable toxicity and degeneration, we suggest that Ser 262 and Ser 356 occupation in the context of adult intact MBs may also mediate dysfunction.
Phosphorylation by Par1 is necessary for MB toxicity and dysfunction
To address these hypotheses, we aimed to determine whether Par1 phosphorylation is important for toxicity and dysfunction of the MBs as well. Hence, we tested two different mutant transgenic proteins for alterations in MB structure and function ( Figure 3A) . The 0N4R-R406W S2A protein [32] contains alanine residues in place of Ser 262 and Ser 356 in the 0N4R-R406W mutant tau background, a human mutation typically associated with FTDP-17 (frontotemporal dementia with parkinsonism on 17) . In addition, we tested these mutations on a WT 2N4R tau protein (2N4R S2A ) [35] . Figure 3( To determine whether the putative Par1 phosphorylation may be important for MB function, we used the Gal80 ts system to express the 2N4R S2A protein specifically in adults. This would overcome potential developmental defects not visible by our histological assessment methods, as shown in Figure 3 (B), but could account for behavioural defects. After 72 h of induction, the 2N4R S2A levels were comparable with those of the similarly induced control 2N4R ( Figure 3C ). In contrast, whereas associative learning of 2N4R-expressing animals was diminished, that of animals harbouring 2N4R
S2A
was not significantly different from controls. Furthermore, the performance of animals expressing 2N4R S2A continuously throughout development was also not different from controls, demonstrating that their MBs are not defective below detection level ( Figure 3D ). Therefore Par1 phosphorylation is essential both for tau toxicity on MB development and for the dysfunction mediated by the protein in these otherwise intact adult neurons. The latter is in agreement with the elevated phosphorylation on Ser 262 and Ser 356 in 2N4R-STA. In conclusion, tau-mediated neuronal toxicity and dysfunction on the same neuronal type appear to be separable temporally. Hyperphosphorylation on some sites can be essential for toxicity or dysfunction and their effects appear to be temporally specific. Furthermore, we have defined two novel phosphorylatable sites, one or both of which appear specifically important for toxicity in Drosophila and potentially in humans as well. These results demonstrate the utility of the Drosophila system in defining and testing the role of novel tau phosphorylatable sites, which may lead to development of new diagnostic antibodies, or therapeutic tools.
